SOURCE: Novo Nordisk A/S

July 14, 2008 08:54 ET

Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - July 14, 2008) - Novo Nordisk A/S - Share repurchase programme


On 31 January 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 2 billion in the period from 31 January 2008 to 6 August 2008.

Since the announcement as of 7 July 2008, the following transactions have been made under the programme:

                  Number of    Average      Transaction
                   shares   purchase price  value, DKK
Accumulated, last 5,055,407                1,622,371,474
announcement
7 July 2008          50,000       301.8350    15,091,750
8 July 2008          55,000       296.7250    16,319,875
9 July 2008          45,000       306.6400    13,798,800
10 July 2008         45,000       309.2850    13,917,825
11 July 2008         45,000       302.9900    13,634,550
Accumulated, 2008 5,295,407                1,695,134,274

With the transactions stated above, Novo Nordisk owns a total of 16,998,930 treasury shares, corresponding to 2.7% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Further information:

Media:                 Investors:

Outside North America: Outside North America:
Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919
ekh@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com

In North America:      In North America:
Sean Clements          Christian Qvist Frandsen
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com   cqfr@novonordisk.com

Stock Exchange Announcement no 44 / 2008


Copyright © Hugin AS 2008. All rights reserved.

Contact Information